Crossmark

High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events

Crossref DOI link: https://doi.org/10.1186/s13014-018-1074-2

Published Online: 2018-07-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Romano, Kara D.

Hill, Colin

Trifiletti, Daniel M.

Peach, M. Sean

Horton, Bethany J.

Shah, Neil

Campbell, Dylan

Libby, Bruce

Showalter, Timothy N. https://orcid.org/0000-0003-1373-8496
License Information

Text and Data Mining valid from 2018-07-16
More Information

Article History

Received: 17 April 2018

Accepted: 10 July 2018

First Online: 16 July 2018

Ethics approval and consent to participate

: The institutional health sciences research board at the University of Virginia waived the need for approval and consent for this study.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.